Compare Stocks

5 / 10
Try these comparisons:

Stock Comparison

VST vs NRG vs CEG vs GEN vs DYN

Revenue, margins, valuation, and 5-year total return — side by side.

Live fundamentals10-year financials5-year price chart
VST
Vistra Corp.

Independent Power Producers

UtilitiesNYSE • US
Market Cap$54.30B
5Y Perf.+635.4%
NRG
NRG Energy, Inc.

Independent Power Producers

UtilitiesNYSE • US
Market Cap$29.97B
5Y Perf.+294.3%
CEG
Constellation Energy Corporation

Renewable Utilities

UtilitiesNASDAQ • US
Market Cap$100.08B
5Y Perf.+567.5%
GEN
Gen Digital Inc.

Software - Infrastructure

TechnologyNASDAQ • US
Market Cap$12.16B
5Y Perf.-24.2%
DYN
Dyne Therapeutics, Inc.

Biotechnology

HealthcareNASDAQ • US
Market Cap$2.88B
5Y Perf.+135.4%

VST vs NRG vs CEG vs GEN vs DYN — Key Financials

Market cap, revenue, margins, and valuation side-by-side.

Company Snapshot
VST logoVST
NRG logoNRG
CEG logoCEG
GEN logoGEN
DYN logoDYN
IndustryIndependent Power ProducersIndependent Power ProducersRenewable UtilitiesSoftware - InfrastructureBiotechnology
Market Cap$54.30B$29.97B$100.08B$12.16B$2.88B
Revenue (TTM)$16.73B$30.71B$25.53B$4.73B$0.00
Net Income (TTM)$944M$864M$2.32B$603M$-446M
Gross Margin15.9%21.8%75.8%77.7%
Operating Margin5.8%6.0%12.1%36.9%
Forward P/E18.7x17.2x27.6x7.7x
Total Debt$20.39B$16.62B$8.99B$8.31B$20M
Cash & Equiv.$816M$260M$3.75B$1.01B$893M

VST vs NRG vs CEG vs GEN vs DYNLong-Term Stock Performance

Price return indexed to 100 at period start. Dividends excluded.

VST
NRG
CEG
GEN
DYN
StockJan 22May 26Return
Vistra Corp. (VST)100735.4+635.4%
NRG Energy, Inc. (NRG)100394.3+294.3%
Constellation Energ… (CEG)100667.5+567.5%
Gen Digital Inc. (GEN)10075.8-24.2%
Dyne Therapeutics, … (DYN)100235.4+135.4%

Price return only. Dividends and distributions are not included.

Quick Verdict: VST vs NRG vs CEG vs GEN vs DYN

Each card shows where this stock fits in a portfolio — not just who wins on paper.

Bottom line: GEN leads in 3 of 7 categories (5-stock set), making it the strongest pick for valuation and capital efficiency and profitability and margin quality. NRG Energy, Inc. is the stronger pick specifically for growth and revenue expansion and operational efficiency and capital deployment. VST and DYN also each lead in at least one category. This set spans 3 sectors — these stocks serve different portfolio roles, not just different price points.
VST
Vistra Corp.
The Long-Run Compounder

VST ranks third and is worth considering specifically for long-term compounding.

  • 9.8% 10Y total return vs NRG's 10.3%
  • 0.6% yield, 6-year raise streak, vs GEN's 2.5%, (2 stocks pay no dividend)
Best for: long-term compounding
NRG
NRG Energy, Inc.
The Growth Play

NRG is the #2 pick in this set and the best alternative if growth exposure is your priority.

  • Rev growth 9.2%, EPS growth -18.0%, 3Y rev CAGR -0.9%
  • 9.2% revenue growth vs DYN's -40.7%
  • 332.3% ROA vs DYN's -50.9%, ROIC 9.1% vs -221.2%
Best for: growth exposure
CEG
Constellation Energy Corporation
The Defensive Pick

CEG is the clearest fit if your priority is sleep-well-at-night and valuation efficiency.

  • Lower volatility, beta 1.44, Low D/E 60.5%, current ratio 1.53x
  • PEG 0.85 vs GEN's 2.83
Best for: sleep-well-at-night and valuation efficiency
GEN
Gen Digital Inc.
The Income Pick

GEN carries the broadest edge in this set and is the clearest fit for income & stability and defensive.

  • Dividend streak 0 yrs, beta 0.98, yield 2.5%
  • Beta 0.98, yield 2.5%, current ratio 0.51x
  • Better valuation composite
  • 12.8% margin vs DYN's 2.0%
Best for: income & stability and defensive
DYN
Dyne Therapeutics, Inc.
The Momentum Pick

DYN is the clearest fit if your priority is momentum.

  • +47.7% vs GEN's -21.6%
Best for: momentum
See the full category breakdown
CategoryWinnerWhy
GrowthNRG logoNRG9.2% revenue growth vs DYN's -40.7%
ValueGEN logoGENBetter valuation composite
Quality / MarginsGEN logoGEN12.8% margin vs DYN's 2.0%
Stability / SafetyGEN logoGENBeta 0.98 vs DYN's 2.34
DividendsVST logoVST0.6% yield, 6-year raise streak, vs GEN's 2.5%, (2 stocks pay no dividend)
Momentum (1Y)DYN logoDYN+47.7% vs GEN's -21.6%
Efficiency (ROA)NRG logoNRG332.3% ROA vs DYN's -50.9%, ROIC 9.1% vs -221.2%

VST vs NRG vs CEG vs GEN vs DYN — Revenue Breakdown by Segment

How each company's revenue is distributed across its business units

VSTVistra Corp.
FY 2025
Retail Segment
51.0%$9.0B
East Segment
23.1%$4.1B
Texas Segment
18.1%$3.2B
Revenue From Other Wholesale Contracts
7.8%$1.4B
NRGNRG Energy, Inc.
FY 2025
East Segment
46.4%$14.3B
Texas Segment
36.2%$11.1B
West, Services and Other Segment
10.4%$3.2B
Vivint Smart Home Segment
7.0%$2.1B
CEGConstellation Energy Corporation
FY 2025
Constellation Mid Atlantic
29.3%$6.5B
Constellation Midwest
26.2%$5.8B
Constellation Other Regions
25.2%$5.6B
Constellation New York
10.8%$2.4B
Constellation ERCOT
8.6%$1.9B
GENGen Digital Inc.
FY 2025
Cyber Safety Revenues
98.7%$3.9B
Legacy
1.3%$50M
DYNDyne Therapeutics, Inc.

Segment breakdown not available.

VST vs NRG vs CEG vs GEN vs DYN — Financial Metrics

Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.

BEST OVERALLGENLAGGINGDYN

Income & Cash Flow (Last 12 Months)

GEN leads this category, winning 6 of 6 comparable metrics.

NRG and DYN operate at a comparable scale, with $30.7B and $0 in trailing revenue. GEN is the more profitable business, keeping 12.8% of every revenue dollar as net income compared to NRG's 2.8%. On growth, GEN holds the edge at +25.8% YoY revenue growth, suggesting stronger near-term business momentum.

MetricVST logoVSTVistra Corp.NRG logoNRGNRG Energy, Inc.CEG logoCEGConstellation Ene…GEN logoGENGen Digital Inc.DYN logoDYNDyne Therapeutics…
RevenueTrailing 12 months$16.7B$30.7B$25.5B$4.7B$0
EBITDAEarnings before interest/tax$4.0B$3.8B$4.7B$2.2B-$466M
Net IncomeAfter-tax profit$944M$864M$2.3B$603M-$446M
Free Cash FlowCash after capex$640M$196M$1.3B$1.5B-$424M
Gross MarginGross profit ÷ Revenue+15.9%+21.8%+75.8%+77.7%
Operating MarginEBIT ÷ Revenue+5.8%+6.0%+12.1%+36.9%
Net MarginNet income ÷ Revenue+5.6%+2.8%+9.1%+12.8%
FCF MarginFCF ÷ Revenue+3.8%+0.6%+5.0%+32.1%
Rev. Growth (YoY)Latest quarter vs prior year-68.2%+13.7%+1.4%+25.8%
EPS Growth (YoY)Latest quarter vs prior year-51.3%-86.3%-49.1%+19.2%+13.6%
GEN leads this category, winning 6 of 6 comparable metrics.

Valuation Metrics

GEN leads this category, winning 3 of 7 comparable metrics.

At 19.1x trailing earnings, GEN trades at a 74% valuation discount to VST's 72.6x P/E. Adjusting for growth (PEG ratio), CEG offers better value at 1.33x vs GEN's 7.00x — a lower PEG means you pay less per unit of expected earnings growth.

MetricVST logoVSTVistra Corp.NRG logoNRGNRG Energy, Inc.CEG logoCEGConstellation Ene…GEN logoGENGen Digital Inc.DYN logoDYNDyne Therapeutics…
Market CapShares × price$54.3B$30.0B$100.1B$12.2B$2.9B
Enterprise ValueMkt cap + debt − cash$73.9B$46.3B$105.3B$19.5B$2.0B
Trailing P/EPrice ÷ TTM EPS72.57x38.49x43.30x19.14x-5.03x
Forward P/EPrice ÷ next-FY EPS est.18.69x17.17x27.62x7.73x
PEG RatioP/E ÷ EPS growth rate6.48x2.64x1.33x7.00x
EV / EBITDAEnterprise value multiple17.24x12.18x25.87x9.60x
Price / SalesMarket cap ÷ Revenue3.20x0.98x3.92x3.09x
Price / BookPrice ÷ Book value/share10.66x19.78x6.77x5.42x2.31x
Price / FCFMarket cap ÷ FCF420.90x39.13x77.71x10.08x
GEN leads this category, winning 3 of 7 comparable metrics.

Profitability & Efficiency

Evenly matched — NRG and DYN each lead in 3 of 9 comparable metrics.

NRG delivers a 51.4% return on equity — every $100 of shareholder capital generates $51 in annual profit, vs $-61 for DYN. DYN carries lower financial leverage with a 0.02x debt-to-equity ratio, signaling a more conservative balance sheet compared to NRG's 9.89x. On the Piotroski fundamental quality scale (0–9), GEN scores 8/9 vs DYN's 4/9, reflecting strong financial health.

MetricVST logoVSTVistra Corp.NRG logoNRGNRG Energy, Inc.CEG logoCEGConstellation Ene…GEN logoGENGen Digital Inc.DYN logoDYNDyne Therapeutics…
ROE (TTM)Return on equity+18.9%+51.4%+15.6%+25.9%-61.5%
ROA (TTM)Return on assets+2.4%+3.3%+4.1%+3.8%-50.9%
ROICReturn on invested capital+4.3%+9.1%+11.9%+12.4%-2.2%
ROCEReturn on capital employed+4.5%+49.7%+6.5%+12.5%-52.4%
Piotroski ScoreFundamental quality 0–947784
Debt / EquityFinancial leverage3.99x9.89x0.61x3.66x0.02x
Net DebtTotal debt minus cash$19.6B$16.4B$5.2B$7.3B-$873M
Cash & Equiv.Liquid assets$816M$260M$3.7B$1.0B$893M
Total DebtShort + long-term debt$20.4B$16.6B$9.0B$8.3B$20M
Interest CoverageEBIT ÷ Interest expense1.95x2.40x6.04x2.97x-71.06x
Evenly matched — NRG and DYN each lead in 3 of 9 comparable metrics.

Total Returns (Dividends Reinvested)

VST leads this category, winning 4 of 6 comparable metrics.

A $10,000 investment in VST five years ago would be worth $101,093 today (with dividends reinvested), compared to $9,815 for DYN. Over the past 12 months, DYN leads with a +47.7% total return vs GEN's -21.6%. The 3-year compound annual growth rate (CAGR) favors VST at 90.9% vs GEN's 7.3% — a key indicator of consistent wealth creation.

MetricVST logoVSTVistra Corp.NRG logoNRGNRG Energy, Inc.CEG logoCEGConstellation Ene…GEN logoGENGen Digital Inc.DYN logoDYNDyne Therapeutics…
YTD ReturnYear-to-date-2.8%-4.7%-12.4%-23.9%-5.6%
1-Year ReturnPast 12 months+15.2%+37.0%+29.7%-21.6%+47.7%
3-Year ReturnCumulative with dividends+596.0%+419.6%+308.4%+23.7%+25.1%
5-Year ReturnCumulative with dividends+910.9%+373.2%+675.0%+4.6%-1.9%
10-Year ReturnCumulative with dividends+983.1%+1027.9%+675.0%+116.9%-26.9%
CAGR (3Y)Annualised 3-year return+90.9%+73.2%+59.8%+7.3%+7.7%
VST leads this category, winning 4 of 6 comparable metrics.

Risk & Volatility

Evenly matched — NRG and GEN each lead in 1 of 2 comparable metrics.

GEN is the less volatile stock with a 0.98 beta — it tends to amplify market swings less than DYN's 2.34 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NRG currently trades 82.9% from its 52-week high vs GEN's 61.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.

MetricVST logoVSTVistra Corp.NRG logoNRGNRG Energy, Inc.CEG logoCEGConstellation Ene…GEN logoGENGen Digital Inc.DYN logoDYNDyne Therapeutics…
Beta (5Y)Sensitivity to S&P 5001.56x1.84x1.44x0.98x2.34x
52-Week HighHighest price in past year$219.82$189.96$412.70$32.22$25.00
52-Week LowLowest price in past year$133.73$114.00$241.46$17.78$8.06
% of 52W HighCurrent price vs 52-week peak+73.0%+82.9%+77.6%+61.2%+69.9%
RSI (14)Momentum oscillator 0–10052.248.060.150.344.5
Avg Volume (50D)Average daily shares traded4.0M2.8M2.8M6.2M2.0M
Evenly matched — NRG and GEN each lead in 1 of 2 comparable metrics.

Analyst Outlook

Evenly matched — NRG and GEN each lead in 1 of 2 comparable metrics.

Analyst consensus: VST as "Buy", NRG as "Buy", CEG as "Buy", GEN as "Buy", DYN as "Buy". Consensus price targets imply 115.2% upside for DYN (target: $38) vs 23.2% for NRG (target: $194). For income investors, GEN offers the higher dividend yield at 2.54% vs CEG's 0.48%.

MetricVST logoVSTVistra Corp.NRG logoNRGNRG Energy, Inc.CEG logoCEGConstellation Ene…GEN logoGENGen Digital Inc.DYN logoDYNDyne Therapeutics…
Analyst RatingConsensus buy/hold/sellBuyBuyBuyBuyBuy
Price TargetConsensus 12-month target$227.60$194.00$405.33$32.00$37.60
# AnalystsCovering analysts2126192113
Dividend YieldAnnual dividend ÷ price+0.6%+0.5%+2.5%
Dividend StreakConsecutive years of raises6730
Dividend / ShareAnnual DPS$0.90$1.55$0.50
Buyback YieldShare repurchases ÷ mkt cap+1.9%0.0%+0.4%+2.2%0.0%
Evenly matched — NRG and GEN each lead in 1 of 2 comparable metrics.
Key Takeaway

GEN leads in 2 of 6 categories (Income & Cash Flow, Valuation Metrics). VST leads in 1 (Total Returns). 3 tied.

Best OverallGen Digital Inc. (GEN)Leads 2 of 6 categories
Loading custom metrics...

VST vs NRG vs CEG vs GEN vs DYN: Key Questions Answered

10 questions · data-driven answers · updated daily

01

Is VST or NRG or CEG or GEN or DYN a better buy right now?

For growth investors, NRG Energy, Inc.

(NRG) is the stronger pick with 9. 2% revenue growth year-over-year, versus -12. 4% for Vistra Corp. (VST). Gen Digital Inc. (GEN) offers the better valuation at 19. 1x trailing P/E (7. 7x forward), making it the more compelling value choice. Analysts rate Vistra Corp. (VST) a "Buy" — based on 21 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

02

Which has the better valuation — VST or NRG or CEG or GEN or DYN?

On trailing P/E, Gen Digital Inc.

(GEN) is the cheapest at 19. 1x versus Vistra Corp. at 72. 6x. On forward P/E, Gen Digital Inc. is actually cheaper at 7. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Constellation Energy Corporation wins at 0. 85x versus Gen Digital Inc. 's 2. 83x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

03

Which is the better long-term investment — VST or NRG or CEG or GEN or DYN?

Over the past 5 years, Vistra Corp.

(VST) delivered a total return of +910. 9%, compared to -1. 9% for Dyne Therapeutics, Inc. (DYN). Over 10 years, the gap is even starker: NRG returned +1028% versus DYN's -26. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

04

Which is safer — VST or NRG or CEG or GEN or DYN?

By beta (market sensitivity over 5 years), Gen Digital Inc.

(GEN) is the lower-risk stock at 0. 98β versus Dyne Therapeutics, Inc. 's 2. 34β — meaning DYN is approximately 139% more volatile than GEN relative to the S&P 500. On balance sheet safety, Dyne Therapeutics, Inc. (DYN) carries a lower debt/equity ratio of 2% versus 10% for NRG Energy, Inc. — giving it more financial flexibility in a downturn.

05

Which is growing faster — VST or NRG or CEG or GEN or DYN?

By revenue growth (latest reported year), NRG Energy, Inc.

(NRG) is pulling ahead at 9. 2% versus -12. 4% for Vistra Corp. (VST). On earnings-per-share growth, the picture is similar: Gen Digital Inc. grew EPS 8. 4% year-over-year, compared to -68. 4% for Vistra Corp.. Over a 3-year CAGR, GEN leads at 12. 1% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

06

Which has better profit margins — VST or NRG or CEG or GEN or DYN?

Gen Digital Inc.

(GEN) is the more profitable company, earning 16. 3% net margin versus 0. 0% for Dyne Therapeutics, Inc. — meaning it keeps 16. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: GEN leads at 40. 9% versus 0. 0% for DYN. At the gross margin level — before operating expenses — GEN leads at 80. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

07

Is VST or NRG or CEG or GEN or DYN more undervalued right now?

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, Constellation Energy Corporation (CEG) is the more undervalued stock at a PEG of 0. 85x versus Gen Digital Inc. 's 2. 83x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Gen Digital Inc. (GEN) trades at 7. 7x forward P/E versus 27. 6x for Constellation Energy Corporation — 19. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for DYN: 115. 2% to $37. 60.

08

Which pays a better dividend — VST or NRG or CEG or GEN or DYN?

In this comparison, GEN (2.

5% yield), VST (0. 6% yield), CEG (0. 5% yield) pay a dividend. NRG, DYN do not pay a meaningful dividend and should not be held primarily for income.

09

Is VST or NRG or CEG or GEN or DYN better for a retirement portfolio?

For long-horizon retirement investors, Vistra Corp.

(VST) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (0. 6% yield, +983. 1% 10Y return). Dyne Therapeutics, Inc. (DYN) carries a higher beta of 2. 34 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (VST: +983. 1%, DYN: -26. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

10

What are the main differences between VST and NRG and CEG and GEN and DYN?

These companies operate in different sectors (VST (Utilities) and NRG (Utilities) and CEG (Utilities) and GEN (Technology) and DYN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

VST, GEN pay a dividend while NRG, CEG, DYN do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.

Find Stocks Like These

Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.

Stocks Like

VST

Stable Dividend Mega-Cap

  • Sector: Utilities
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

NRG

Quality Business

  • Sector: Utilities
  • Market Cap > $100B
  • Revenue Growth > 6%
  • Gross Margin > 13%
Run This Screen
Stocks Like

CEG

Stable Dividend Mega-Cap

  • Sector: Utilities
  • Market Cap > $100B
  • Net Margin > 5%
  • Dividend Yield > 0.5%
Run This Screen
Stocks Like

GEN

High-Growth Compounder

  • Sector: Technology
  • Market Cap > $100B
  • Revenue Growth > 12%
  • Net Margin > 7%
Run This Screen
Stocks Like

DYN

Quality Business

  • Sector: Healthcare
  • Market Cap > $100B
Run This Screen
Custom Screen

Beat Both

Find stocks that outperform VST and NRG and CEG and GEN and DYN on the metrics below

Revenue Growth>
%
(VST: -68.2% · NRG: 13.7%)
Net Margin>
%
(VST: 5.6% · NRG: 2.8%)
P/E Ratio<
x
(VST: 72.6x · NRG: 38.5x)

You Might Also Compare

Based on how these companies actually compete and overlap — not just which sector they're filed under.